Tocopherols inhibit oxidative and nitrosative stress in estrogen-induced early mammary hyperplasia in ACI rats

Molecular Carcinogenesis

Volumn 54, Issue 9, 2015, Pages 916-925

  Das Gupta, Soumyasri ^a   So, Jae Young ^a   Wall, Brian ^a   Wahler, Joseph ^a   Smolarek, Amanda K ^a   Sae tan, Sudathip ^a   Soewono, Kelvin Y ^a   Yu, Haixiang ^a   Lee, Mao Jung ^a   Thomas, Paul E ^a   Yang, Chung S ^a,b   Suh, Nanjoo ^a,b  

^a RUTGERS UNIVERSITY   (United States)

^b RUTGERS CANCER INSTITUTE OF NEW JERSEY   (United States)

Author keywords

Breast cancer; Estrogen; Oxidative stress; Vitamin E

Indexed keywords

3 NITROTYROSINE; 8 ISOPROSTANE; CATALASE; ESTRADIOL; GLUTATHIONE PEROXIDASE; MESSENGER RNA; SUPEROXIDE DISMUTASE; TOCOPHEROL; 3-NITROTYROSINE; ANTIOXIDANT; ESTROGEN; NFE2L2 PROTEIN, RAT; TRANSCRIPTION FACTOR NRF2; TYROSINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; AUGUST COPENHAGEN IRISH RAT; BREAST CARCINOGENESIS; BREAST HYPERPLASIA; CELL PROTECTION; CHEMOPROPHYLAXIS; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; HISTOLOGY; NITROSATIVE STRESS; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; ANALOGS AND DERIVATIVES; ANALYSIS; ANIMAL; BREAST DISEASE; CHEMICALLY INDUCED; DIET SUPPLEMENTATION; DIET THERAPY; DRUG EFFECTS; GENETICS; HUMAN; HYPERPLASIA; METABOLISM; PATHOLOGY; UDDER; UPREGULATION;

RATTUS; RODENTIA;

ANIMALS; ANTIOXIDANTS; BREAST DISEASES; DIETARY SUPPLEMENTS; ESTROGENS; FEMALE; HUMANS; HYPERPLASIA; MAMMARY GLANDS, ANIMAL; NF-E2-RELATED FACTOR 2; OXIDATIVE STRESS; RATS; RATS, INBRED ACI; RNA, MESSENGER; TOCOPHEROLS; TYROSINE; UP-REGULATION;

EID: 84938914346     PISSN: 08991987     EISSN: 10982744     Source Type: Journal    
DOI: 10.1002/mc.22164     Document Type: Article

References (48)

1. Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014; 64:9-29.
2. Cavalieri E, Chakravarti D, Guttenplan J, et al. Catechol estrogen quinones as initiators of breast and other human cancers: Implications for biomarkers of susceptibility and cancer prevention. Biochim Biophys Acta 2006; 1766:63-78.
3. Cavalieri E, Rogan E. Catechol quinones of estrogens in the initiation of breast, prostate, and other human cancers: Keynote lecture. Ann N Y Acad Sci 2006; 1089:286-301.
4. Cavalieri EL, Stack DE, Devanesan PD, et al. Molecular origin of cancer: Catechol estrogen-3, 4-quinones as endogenous tumor initiators. Proc Natl Acad Sci USA 1997; 94:10937-10942.
5. Clemons M, Goss P. Estrogen and the risk of breast cancer. N Engl J Med 2001; 344:276-285.
6. Bhat HK, Calaf G, Hei TK, Loya T, Vadgama JV. Critical role of oxidative stress in estrogen-induced carcinogenesis. Proc Natl Acad Sci USA 2003; 100:3913-3918.
7. Yue W, Yager JD, Wang JP, Jupe ER, Santen RJ. Estrogen receptor-dependent and independent mechanisms of breast cancer carcinogenesis. Steroids 2013; 78:161-170.
8. Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Engl J Med 2006; 354:270-282.
9. Mense SM, Remotti F, Bhan A, et al. Estrogen-induced breast cancer: Alterations in breast morphology and oxidative stress as a function of estrogen exposure. Toxicol Appl Pharmacol 2008; 232:78-85.
10. Roy D, Cai Q, Felty Q, Narayan S. Estrogen-induced generation of reactive oxygen and nitrogen species, gene damage, and estrogen-dependent cancers. J Toxicol Environ Health B Crit Rev 2007; 10:235-257.
11. Constantinou C, Papas A, Constantinou AI. Vitamin E and cancer: An insight into the anticancer activities of vitamin E isomers and analogs. Int J Cancer 2008; 123:739-752.
12. Taylor PR, Qiao YL, Abnet CC, et al. Prospective study of serum vitamin E levels and esophageal and gastric cancers. J Natl Cancer Inst 2003; 95:1414-1416.
13. Ju J, Picinich SC, Yang Z, et al. Cancer-preventive activities of tocopherols and tocotrienols. Carcinogenesis 2010; 31:533-542.
14. Brigelius-Flohe R, Kelly FJ, Salonen JT, Neuzil J, Zingg JM, Azzi A. The European perspective on vitamin E: Current knowledge and future research. Am J Clin Nutr 2002; 76:703-716.
15. Lee IM, Cook NR, Gaziano JM, et al. Vitamin E in the primary prevention of cardiovascular disease and cancer: The Women's Health Study: A randomized controlled trial. JAMA 2005; 294:56-65.
16. Blumberg J, Block G. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study in Finland. Nutr Rev 1994; 52:242-245.
17. Lippman SM, Klein EA, Goodman PJ, et al. Effect of selenium and vitamin E on risk of prostate cancer and other cancers: The Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA 2009; 301:39-51.
18. Gaziano JM, Glynn RJ, Christen WG, et al. Vitamins E and C in the prevention of prostate and total cancer in men: The Physicians' Health Study II randomized controlled trial. JAMA 2009; 301:52-62.
19. Jiang Q, Christen S, Shigenaga MK, Ames BN. gamma-tocopherol, the major form of vitamin E in the US diet, deserves more attention. Am J Clin Nutr 2001; 74:714-722.
20. Ju J, Hao X, Lee MJ, et al. A gamma-tocopherol-rich mixture of tocopherols inhibits colon inflammation and carcinogenesis in azoxymethane and dextran sulfate sodium-treated mice. Cancer Prev Res (Phila) 2009; 2:143-152.
21. Lu G, Xiao H, Li G-X, et al. A γ-tocopherol-rich mixture of tocopherols inhibits chemically induced lung tumorigenesis in A/J mice and xenograft tumor growth. Carcinogenesis 2010; 31:687-694.
22. Smolarek AK, So JY, Burgess B, et al. Dietary administration of delta- and gamma-tocopherol inhibits tumorigenesis in the animal model of estrogen receptor-positive, but not HER-2 breast cancer. Cancer Prev Res (Phila) 2012; 5:1310-1320.
23. Lambert JD, Lu G, Lee MJ, Hu J, Ju J, Yang CS. Inhibition of lung cancer growth in mice by dietary mixed tocopherols. Mol Nutr Food Res 2009; 53:1030-1035.
24. Lee HJ, Ju J, Paul S, et al. Mixed tocopherols prevent mammary tumorigenesis by inhibiting estrogen action and activating PPAR-gamma. Clin Cancer Res 2009; 15:4242-4249.
25. Shull JD, Spady TJ, Snyder MC, Johansson SL, Pennington KL. Ovary-intact, but not ovariectomized female ACI rats treated with 17beta-estradiol rapidly develop mammary carcinoma. Carcinogenesis 1997; 18:1595-1601.
26. Li JJ, Papa D, Davis MF, et al. Ploidy differences between hormone- and chemical carcinogen-induced rat mammary neoplasms: Comparison to invasive human ductal breast cancer. Mol Carcinog 2002; 33:56-65.
27. Li JJ, Weroha SJ, Lingle WL, Papa D, Salisbury JL, Li SA. Estrogen mediates Aurora-A overexpression, centrosome amplification, chromosomal instability, and breast cancer in female ACI rats. Proc Natl Acad Sci USA 2004; 101:18123-18128.
28. Li SA, Weroha SJ, Tawfik O, Li JJ. Prevention of solely estrogen-induced mammary tumors in female aci rats by tamoxifen: Evidence for estrogen receptor mediation. J Endocrinol 2002; 175:297-305.
29. Makris A, Allred DC, Powles TJ, et al. Cytological evaluation of biological prognostic markers from primary breast carcinomas. Breast Cancer Res Treat 1997; 44:65-74.
30. Kurz SG, Hansen KK, McLaughlin MT, et al. Tissue-specific actions of the Ept1, Ept2, Ept6, and Ept9 genetic determinants of responsiveness to estrogens in the female rat. Endocrinology 2008; 149:3850-3859.
31. Smolarek AK, So JY, Thomas PE, et al. Dietary tocopherols inhibit cell proliferation, regulate expression of ERalpha, PPARgamma, and Nrf2, and decrease serum inflammatory markers during the development of mammary hyperplasia. Mol Carcinog 2013; 52:514-525.
32. Turan VK, Sanchez RI, Li JJ, et al. The effects of steroidal estrogens in ACI rat mammary carcinogenesis: 17beta-estradiol, 2-hydroxyestradiol, 4-hydroxyestradiol, 16alpha-hydroxyestradiol, and 4-hydroxyestrone. J Endocrinol 2004; 183:91-99.
33. Zhao Y, Lee MJ, Cheung C, et al. Analysis of multiple metabolites of tocopherols and tocotrienols in mice and humans. J Agric Food Chem 2010; 58:4844-4852.
34. Lee HJ, Liu H, Goodman C, et al. Gene expression profiling changes induced by a novel Gemini Vitamin D derivative during the progression of breast cancer. Biochem Pharmacol 2006; 72:332-343.
35. Ravoori S, Vadhanam MV, Sahoo S, Srinivasan C, Gupta RC. Mammary tumor induction in ACI rats exposed to low levels of 17beta-estradiol. Int J Oncol 2007; 31:113-120.
36. Baraldi E, Giordano G, Pasquale MF, et al. 3-Nitrotyrosine, a marker of nitrosative stress, is increased in breath condensate of allergic asthmatic children. Allergy 2006; 61:90-96.
37. Valavanidis A, Vlachogianni T, Fiotakis C. 8-hydroxy-2′-deoxyguanosine (8-OHdG): A critical biomarker of oxidative stress and carcinogenesis. J Environ Sci Health C Environ Carcinog Ecotoxicol Rev 2009; 27:120-139.
38. Montuschi P, Barnes PJ, Roberts LJ II. Isoprostanes: Markers and mediators of oxidative stress. FASEB J 2004; 18:1791-1800.
39. Frohlich DA, McCabe MT, Arnold RS, Day ML. The role of Nrf2 in increased reactive oxygen species and DNA damage in prostate tumorigenesis. Oncogene 2008; 27:4353-4362.
40. Lim E, Metzger-Filho O, Winer EP. The natural history of hormone receptor-positive breast cancer. Oncology (Williston Park) 2012; 26:688-694, 696.
41. Schumacker PT. Reactive oxygen species in cancer cells: Live by the sword, die by the sword. Cancer Cell 2006; 10:175-176.
42. Cavalieri EL, Rogan EG. A unified mechanism in the initiation of cancer. Ann N Y Acad of Sci 2002; 959:341-354.
43. Arsova-Sarafinovska Z, Eken A, Matevska N, et al. Increased oxidative/nitrosative stress and decreased antioxidant enzyme activities in prostate cancer. Clinl Biochem 2009; 42:1228-1235.
44. Kensler TW, Wakabayashi N. Nrf2: Friend or foe for chemoprevention? Carcinogenesis 2010; 31:90-99.
45. Becks L, Prince M, Burson H, et al. Aggressive mammary carcinoma progression in Nrf2 knockout mice treated with 7, 12-dimethylbenz [a] anthracene. BMC Cancer 2010; 10:540.
46. Barve A, Khor TO, Nair S, et al. γ-Tocopherol-enriched mixed tocopherol diet inhibits prostate carcinogenesis in TRAMP mice. Int J Cancer 2009; 124:1693-1699.
47. Singh B, Bhat NK, Bhat HK. Induction of NAD (P) H-quinone oxidoreductase 1 by antioxidants in female ACI rats is associated with decrease in oxidative DNA damage and inhibition of estrogen-induced breast cancer. Carcinogenesis 2012; 33:156-163.
48. Matés J. Effects of antioxidant enzymes in the molecular control of reactive oxygen species toxicology. Toxicology 2000; 153:83-104.